Vantage logo

Enhertu tightens its stranglehold

The Astra/Daiichi antibody-drug conjugate could eat into Roche’s breast cancer dominance, courtesy of a clinical hit in Her2-low disease.

Vantage logo

Vantage Esmo 2021 roundup

Here's a roundup of Vantage's coverage of the 2021 European Society for Medical Oncology congress.

Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.